Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population Treated With Immune Checkpoint Inhibitors for Various Cancers

NCT05863052 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT05863052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05863052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population Treated With Immune Checkpoint Inhibitors for Various Cancers
Lead sponsor
University of Oklahoma
Phase
Observational
Overall status
Active, not recruiting
Start date
January 31, 2022
Completion date
December 31, 2027
Enrollment
72 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancer, immune checkpoint inhibitors, melanoma, metastatic solid tumor, nonsmall cell lung cancer, renal cell carcinoma, squamous cell carcinoma